CD46 and systemic lupus erythematosus: To assess the regulatory capacity of CD46‐activated SLE T cells, freshly isolated autologous CD4+ T cells were activated with antibodies to either CD3 or CD3+CD28 in the presence of supernatants derived from CD3+CD46‐activated T cells from HCs or SLE patients and cell proliferation measured 6 days post‐activation.